Vaccination recommendations and risk of meningitis following cochlear implantation.

Abstract

PURPOSE OF REVIEW:

The Centers for Disease Control and Prevention has established vaccination guidelines for cochlear implant recipients to address the concern for implant-associated bacterial meningitis. Since their inception in 2002, these guidelines have undergone several revisions. We review the rationale and development of the current vaccination schedule.

RECENT FINDINGS:

Bacterial meningitis is a rare yet potentially life-threatening complication of cochlear implantation. The recommendations for pneumococcal vaccination have evolved to a state in which nearly all cochlear implant patients receive a combination of both the PCV7 or PCV13 and PPSV23.

SUMMARY:

Streptococcus pneumoniae vaccinations have dramatically decreased the incidence of serotype-specific invasive pneumococcal disease across all age groups. However, the optimal timing of immunization remains unclear in cochlear implant candidates.

• Authors: Charissa N Kahue, Alex D Sweeney, Matthew L Carlson, David S Haynes
• Journal: Current opinion in otolaryngology & head and neck surgery (Curr Opin Otolaryngol Head Neck Surg) Vol. 22 Issue 5 Pg. 359-66 (Oct 2014) ISSN: 1531-6998 [Electronic] United States
• PMID: 25101934 (Publication Type: Journal Article)

Chemical References

• Heptavalent Pneumococcal Conjugate Vaccine
• Pneumococcal Vaccines
• Vaccines, Conjugate

Topics

• Acute Disease
• Cochlear Implantation (adverse effects)
• Heptavalent Pneumococcal Conjugate Vaccine
• Humans
• Immunization Schedule
• Meningitis, Pneumococcal (epidemiology, etiology, prevention & control)
• Otitis Media (complications)
• Pneumococcal Vaccines (therapeutic use)
• Risk Factors
• Vaccination (standards)
• Vaccines, Conjugate (therapeutic use)